Avanir's Zenvia meets study goal, shares jump: Associated Press Business News: AVNR - MSN Money: "NEW YORK (AP) - Shares of Avanir Pharmaceuticals surged in premarket trading after the company said a new formula of its drug Zenvia met the main goal of a late-stage study.
The drug is aimed at reducing emotional outbursts, including uncontrolled crying or laughing, as part of a disorder called pseudobulbar affect.
The company's stock rose $1.66, or 76 percent, to $3.85 in premarket trading after closing at $2.19 during the regular trading session Monday."
www.stockcaps.blogspot.com
 | Company Earnings Earnings Dates, Surprises, Conference Calls |  | Financial Calendars Stock Splits, Economic, IPOs, Mergers |
 | Analyst Research Report Screener, Analyst Performance Center, Up/Downgrades, Sector/Industry Analysis |  | Research Tools Stock Screener, Historical Quotes, Real-Time Quotes |
 | Company Reports Annual Reports, SEC Filings, Financial Statements |  | Bonds Bond Center, Bond Screener, Bond News, Bond Rates |
 | Mutual Funds Mutual Fund Center, Fund Screener, Top Performers |  | Options Options Center, Options News, Options 101 |
Sunday, August 16, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment